| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
This article has been cited by other articles:
![]() |
A. Mueller, C. Schofl, R. Dittrich, S. Cupisti, P.G. Oppelt, R.L. Schild, M.W. Beckmann, and L. Haberle Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome Hum. Reprod., November 1, 2009; 24(11): 2924 - 2930. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. de Zegher and L. Ibanez Early Origins of Polycystic Ovary Syndrome: Hypotheses May Change without Notice J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3682 - 3685. [Full Text] [PDF] |
||||
![]() |
E Wehr, S Pilz, N Schweighofer, A Giuliani, D Kopera, T R Pieber, and B Obermayer-Pietsch Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome Eur. J. Endocrinol., October 1, 2009; 161(4): 575 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Franks Do Animal Models of Polycystic Ovary Syndrome Help to Understand Its Pathogenesis and Management? Yes, but Their Limitations Should be Recognized Endocrinology, September 1, 2009; 150(9): 3983 - 3985. [Full Text] [PDF] |
||||
![]() |
V. M. Victor, M. Rocha, C. Banuls, M. Sanchez-Serrano, E. Sola, M. Gomez, and A. Hernandez-Mijares Mitochondrial Complex I Impairment in Leukocytes from Polycystic Ovary Syndrome Patients with Insulin Resistance J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3505 - 3512. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Shi, M. K. Dyck, R. R. E. Uwiera, J. C. Russell, S. D. Proctor, and D. F. Vine A Unique Rodent Model of Cardiometabolic Risk Associated with the Metabolic Syndrome and Polycystic Ovary Syndrome Endocrinology, September 1, 2009; 150(9): 4425 - 4436. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Tan, J. Chen, S. Farhatullah, R. Adya, J. Kaur, D. Heutling, K. C. Lewandowski, J. P. O'Hare, H. Lehnert, and H. S. Randeva Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin Diabetes, September 1, 2009; 58(9): 1971 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Koika, D. J Marioli, A. D Saltamavros, V. Vervita, K. D Koufogiannis, G. Adonakis, G. Decavalas, and N. A Georgopoulos Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor {gamma}2 with decreased basic metabolic rate in women with polycystic ovary syndrome Eur. J. Endocrinol., August 1, 2009; 161(2): 317 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Seow, Y.-L. Tsai, J.-L. Hwang, W.-Y. Hsu, L.-T. Ho, and C.-C. Juan Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome Hum. Reprod., August 1, 2009; 24(8): 1982 - 1988. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Tan, R. Adya, J. Chen, S. Farhatullah, D. Heutling, D. Mitchell, H. Lehnert, and H. S. Randeva Metformin decreases angiogenesis via NF-{kappa}B and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1 Cardiovasc Res, August 1, 2009; 83(3): 566 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Blank, C. R. McCartney, S. Chhabra, K. D. Helm, C. A. Eagleson, R. J. Chang, and J. C. Marshall Modulation of Gonadotropin-Releasing Hormone Pulse Generator Sensitivity to Progesterone Inhibition in Hyperandrogenic Adolescent Girls--Implications for Regulation of Pubertal Maturation J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2360 - 2366. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Padmanabhan Polycystic Ovary Syndrome -- "A Riddle Wrapped in a Mystery inside an Enigma" J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1883 - 1885. [Full Text] [PDF] |
||||
![]() |
T. Sir-Petermann, E. Codner, V. Perez, B. Echiburu, M. Maliqueo, A. Ladron de Guevara, J. Preisler, N. Crisosto, F. Sanchez, F. Cassorla, et al. Metabolic and Reproductive Features before and during Puberty in Daughters of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1923 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iwase, M. Goto, T. Harata, S. Takigawa, T. Nakahara, K. Suzuki, S. Manabe, and F. Kikkawa Insulin Attenuates the Insulin-Like Growth Factor-I (IGF-I)-Akt Pathway, not IGF-I-Extracellularly Regulated Kinase Pathway, in Luteinized Granulosa Cells with an Increase in PTEN J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2184 - 2191. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Cho, V Jayagopal, E S Kilpatrick, and S L Atkin The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes Ann Clin Biochem, May 1, 2009; 46(3): 218 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Diamanti-Kandarakis, A. Piouka, S. Livadas, C. Piperi, I. Katsikis, A. G Papavassiliou, and D. Panidis Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome Eur. J. Endocrinol., May 1, 2009; 160(5): 847 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mukherjee, N. Shaikh, S. Khavale, G. Shinde, P. Meherji, N. Shah, and A. Maitra Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome Eur. J. Endocrinol., May 1, 2009; 160(5): 855 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hirshfeld-Cytron, R. B. Barnes, D. A. Ehrmann, A. Caruso, M. M. Mortensen, and R. L. Rosenfield Characterization of Functionally Typical and Atypical Types of Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1587 - 1594. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H Ortega, N. R Salvetti, and V. Padmanabhan Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance Reproduction, May 1, 2009; 137(5): 865 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Balen, R. Homburg, and S. Franks Defining polycystic ovary syndrome BMJ, February 13, 2009; 338(feb13_2): a2968 - a2968. [Full Text] |
||||
![]() |
S. Palomba, A. Falbo, F. Zullo, and F. Orio Jr. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review Endocr. Rev., February 1, 2009; 30(1): 1 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Richardson, S. Ingamells, C. D. Simonis, I. T. Cameron, R. Sreekumar, A. Vijendren, L. Sellahewa, S. Coakley, and C. D. Byrne Stimulation of Lactate Production in Human Granulosa Cells by Metformin and Potential Involvement of Adenosine 5' Monophosphate-Activated Protein Kinase J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 670 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wang, L. Wang, Y. Zhao, Y. Shi, L. Wang, and Z.-J. Chen No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene and polycystic ovary syndrome Hum. Reprod., February 1, 2009; 24(2): 485 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Velazquez, J Zaraza, A Oropeza, R Webb, and H Niemann The role of IGF1 in the in vivo production of bovine embryos from superovulated donors Reproduction, February 1, 2009; 137(2): 161 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Piouka, D. Farmakiotis, I. Katsikis, D. Macut, S. Gerou, and D. Panidis Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels Am J Physiol Endocrinol Metab, February 1, 2009; 296(2): E238 - E243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dorfman, V. D. Ramirez, E. Stener-Victorin, and H. E. Lara Chronic-Intermittent Cold Stress in Rats Induces Selective Ovarian Insulin Resistance Biol Reprod, February 1, 2009; 80(2): 264 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sattar Review: PCOS, insulin resistance and long-term risks for diabetes and vascular disease The British Journal of Diabetes & Vascular Disease, January 1, 2009; 9(1): 15 - 18. [Abstract] [PDF] |
||||
![]() |
S. M Nelson Obesity, insulin resistance and assisted conception The British Journal of Diabetes & Vascular Disease, January 1, 2009; 9(1): 23 - 26. [Abstract] [PDF] |
||||
![]() |
A.E. Nieuwenhuis-Ruifrok, W.K.H. Kuchenbecker, A. Hoek, P. Middleton, and R.J. Norman Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis Hum. Reprod. Update, January 1, 2009; 15(1): 57 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rossi, S. Sukalich, J. Droz, A. Griffin, S. Cook, A. Blumkin, D. S. Guzick, and K. M. Hoeger Prevalence of Metabolic Syndrome and Related Characteristics in Obese Adolescents with and without Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4780 - 4786. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, E. Calvo, C. Martel, V. Luu-The, F. Labrie, and A. Tchernof Response of the adipose tissue transcriptome to dihydrotestosterone in mice Physiol Genomics, November 12, 2008; 35(3): 254 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tasali, E. Van Cauter, L. Hoffman, and D. A. Ehrmann Impact of Obstructive Sleep Apnea on Insulin Resistance and Glucose Tolerance in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3878 - 3884. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mai, T. Bobbert, F. Reinecke, J. Andres, C. Maser-Gluth, S. A. Wudy, M. Mohlig, M. O. Weickert, M. F. Hartmann, H. M. Schulte, et al. Intravenous Lipid and Heparin Infusion-Induced Elevation in Free Fatty Acids and Triglycerides Modifies Circulating Androgen Levels in Women: A Randomized, Controlled Trial J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3900 - 3906. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Gambineri, R K Semple, G Forlani, S Genghini, I Grassi, C S S Hyden, U Pagotto, S O'Rahilly, and R Pasquali Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin Eur. J. Endocrinol., September 1, 2008; 159(3): 347 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Moll, J.C. Korevaar, P.M.M. Bossuyt, and F. van der Veen Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome? Hum. Reprod., August 1, 2008; 23(8): 1830 - 1834. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Demissie, M. Lazic, E. M. Foecking, F. Aird, A. Dunaif, and J. E. Levine Transient prenatal androgen exposure produces metabolic syndrome in adult female rats Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E262 - E268. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Barber, M. Hazell, C. Christodoulides, S. J. Golding, C. Alvey, K. Burling, A. Vidal-Puig, N. P. Groome, J. A. H. Wass, S. Franks, et al. Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2859 - 2865. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Elkind-Hirsch, O. Marrioneaux, M. Bhushan, D. Vernor, and R. Bhushan Comparison of Single and Combined Treatment with Exenatide and Metformin on Menstrual Cyclicity in Overweight Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2670 - 2678. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Fenkci, V. Fenkci, O. Oztekin, S. Rota, and N. Karagenc Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome Hum. Reprod., July 1, 2008; 23(7): 1602 - 1606. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jensterle, A. Janez, B. Mlinar, J. Marc, J. Prezelj, and M. Pfeifer Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome. Eur. J. Endocrinol., June 1, 2008; 158(6): 793 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rachmiel, S. Kives, E. Atenafu, and J. Hamilton Primary Amenorrhea as a Manifestation of Polycystic Ovarian Syndrome in Adolescents: A Unique Subgroup? Arch Pediatr Adolesc Med, June 1, 2008; 162(6): 521 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.P. Cheung, R.C.W. Ma, P.M. Lam, I.H. Lok, C.J. Haines, W.Y. So, P.C.Y. Tong, C.S. Cockram, C.C. Chow, and W.B. Goggins Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome Hum. Reprod., June 1, 2008; 23(6): 1431 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Tan, D. Heutling, J. Chen, S. Farhatullah, R. Adya, S. D. Keay, C. R. Kennedy, H. Lehnert, and H. S. Randeva Metformin Decreases the Adipokine Vaspin in Overweight Women With Polycystic Ovary Syndrome Concomitant With Improvement in Insulin Sensitivity and a Decrease in Insulin Resistance Diabetes, June 1, 2008; 57(6): 1501 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Franks, J. Stark, and K. Hardy Follicle dynamics and anovulation in polycystic ovary syndrome Hum. Reprod. Update, May 22, 2008; (2008) dmn015v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Cupisti, N Kajaia, R Dittrich, H Duezenli, M W Beckmann, and A Mueller Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome Eur. J. Endocrinol., May 1, 2008; 158(5): 711 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Recabarren, R. Smith, R. Rios, M. Maliqueo, B. Echiburu, E. Codner, F. Cassorla, P. Rojas, and T. Sir-Petermann Metabolic Profile in Sons of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1820 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mohlig, M. O Weickert, E. Ghadamgahi, A. M Arafat, J. Spranger, A. F H Pfeiffer, and C. Schofl Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome. Eur. J. Endocrinol., April 1, 2008; 158(4): 517 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Diamanti-Kandarakis, S. Livadas, S. A Kandarakis, A. Margeli, and I. Papassotiriou Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism? Eur. J. Endocrinol., April 1, 2008; 158(4): 525 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Tan, R. Adya, S. Farhatullah, K. C. Lewandowski, P. O'Hare, H. Lehnert, and H. S. Randeva Omentin-1, a Novel Adipokine, Is Decreased in Overweight Insulin-Resistant Women With Polycystic Ovary Syndrome: Ex Vivo and In Vivo Regulation of Omentin-1 by Insulin and Glucose Diabetes, April 1, 2008; 57(4): 801 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chakrabarty and M. Nagamani Peripubertal Hyperinsulinemia Upregulates Phosphatidylinositol 3-Kinase/Akt Pathway in Rat Ovaries Reproductive Sciences, March 1, 2008; 15(3): 274 - 284. [Abstract] [PDF] |
||||
![]() |
T. M. Barber, S. J. Golding, C. Alvey, J. A. H. Wass, F. Karpe, S. Franks, and M. I. McCarthy Global Adiposity Rather Than Abnormal Regional Fat Distribution Characterizes Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 999 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Heutling, H. Schulz, I. Nickel, J. Kleinstein, P. Kaltwasser, S. Westphal, F. Mittermayer, M. Wolzt, K. Krzyzanowska, H. Randeva, et al. Asymmetrical Dimethylarginine, Inflammatory and Metabolic Parameters in Women with Polycystic Ovary Syndrome before and after Metformin Treatment J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 82 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J Moran, M. Noakes, P. M Clifton, G. A Wittert, C. W Le Roux, M. A Ghatei, S. R Bloom, and R. J Norman Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1603 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Roberge, A. C. Carpentier, M.-F. Langlois, J.-P. Baillargeon, J.-L. Ardilouze, P. Maheux, and N. Gallo-Payet Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1465 - E1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vigil, P. Contreras, J. L. Alvarado, A. Godoy, A. M. Salgado, and M. E. Cortes Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome Hum. Reprod., November 1, 2007; 22(11): 2974 - 2980. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kajaia, H. Binder, R. Dittrich, P. G Oppelt, B. Flor, S. Cupisti, M. W Beckmann, and A. Mueller Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome Eur. J. Endocrinol., October 1, 2007; 157(4): 499 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Skov, D. Glintborg, S. Knudsen, T. Jensen, T. A. Kruse, Q. Tan, K. Brusgaard, H. Beck-Nielsen, and K. Hojlund Reduced Expression of Nuclear-Encoded Genes Involved in Mitochondrial Oxidative Metabolism in Skeletal Muscle of Insulin-Resistant Women With Polycystic Ovary Syndrome Diabetes, September 1, 2007; 56(9): 2349 - 2355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mohlig, M. O Weickert, E. Ghadamgadai, A. Machlitt, B. Pfuller, A. M Arafat, A. F H Pfeiffer, and C. Schofl Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women Eur. J. Endocrinol., August 1, 2007; 157(2): 195 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Moran, M. Noakes, P. M. Clifton, G. A. Wittert, D. P. Belobrajdic, and R. J. Norman C-Reactive Protein before and after Weight Loss in Overweight Women with and without Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2944 - 2951. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Palomba, A. Falbo, T. Russo, F. Manguso, A. Tolino, F. Zullo, P. De Feo, and F. Orio Jr. Insulin Sensitivity after Metformin Suspension in Normal-Weight Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3128 - 3135. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ma, L. Fan, Y. Meng, Z. Hou, Y.-D. Mao, W. Wang, W. Ding, and J.-Y. Liu Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome Mol. Hum. Reprod., August 1, 2007; 13(8): 527 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Carmina, S. Bucchieri, A. Esposito, A. Del Puente, P. Mansueto, F. Orio, G. Di Fede, and G. Rini Abdominal Fat Quantity and Distribution in Women with Polycystic Ovary Syndrome and Extent of Its Relation to Insulin Resistance J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2500 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Luque-Ramirez, F. Alvarez-Blasco, J. I. Botella-Carretero, E. Martinez-Bermejo, M. A. Lasuncion, and H. F. Escobar-Morreale Comparison of Ethinyl-Estradiol Plus Cyproterone Acetate Versus Metformin Effects on Classic Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2453 - 2461. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Tan, J. Chen, H. Lehnert, R. Kennedy, and H. S. Randeva Raised Serum, Adipocyte, and Adipose Tissue Retinol-Binding Protein 4 in Overweight Women with Polycystic Ovary Syndrome: Effects of Gonadal and Adrenal Steroids J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2764 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sir-Petermann, B. Echiburu, M M. Maliqueo, N. Crisosto, F. Sanchez, C. Hitschfeld, M. Carcamo, P. Amigo, and F. Perez-Bravo Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome Hum. Reprod., July 1, 2007; 22(7): 1830 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Luque-Ramirez, F. Alvarez-Blasco, C. Mendieta-Azcona, J. I. Botella-Carretero, and H. F. Escobar-Morreale Obesity Is the Major Determinant of the Abnormalities in Blood Pressure Found in Young Women with the Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2141 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.L. Hendriks, J.C.F. Ket, P.G.A. Hompes, R. Homburg, and C.B. Lambalk Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome Hum. Reprod. Update, May 1, 2007; 13(3): 249 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Codner and H. F. Escobar-Morreale Hyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1209 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Seow, C.-C. Juan, Y.-P. Hsu, J.-L. Hwang, L.-W. Huang, and L.-T. Ho Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery Hum. Reprod., April 1, 2007; 22(4): 1003 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Seow, C.-C. Juan, L.-T. Ho, Y.-P. Hsu, Y.-H. Lin, L.-W. Huang, and J.-L. Hwang Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome Hum. Reprod., April 1, 2007; 22(4): 1100 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E Kasim-Karakas, W. M Cunningham, and A. Tsodikov Relation of nutrients and hormones in polycystic ovary syndrome Am. J. Clinical Nutrition, March 1, 2007; 85(3): 688 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Corbould Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women J. Endocrinol., March 1, 2007; 192(3): 585 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Legro A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome JAMA, February 7, 2007; 297(5): 509 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Tan, J. Chen, J. E. Digby, S. D. Keay, C. R. Kennedy, and H. S. Randeva Increased Visfatin Messenger Ribonucleic Acid and Protein Levels in Adipose Tissue and Adipocytes in Women with Polycystic Ovary Syndrome: Parallel Increase in Plasma Visfatin J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5022 - 5028. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, E. S. Ford, L. C. McGuire, A. H. Mokdad, R. R. Little, and G. M. Reaven Trends in hyperinsulinemia among nondiabetic adults in the u.s. Diabetes Care, November 1, 2006; 29(11): 2396 - 2402. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Alvarez-Blasco, J. I. Botella-Carretero, J. L. San Millan, and H. F. Escobar-Morreale Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med, October 23, 2006; 166(19): 2081 - 2086. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Hoppin, E. S. Katz, L. M. Kaplan, and G. Y. Lauwers Case 31-2006 -- A 15-Year-Old Girl with Severe Obesity. N. Engl. J. Med., October 12, 2006; 355(15): 1593 - 1602. [Full Text] [PDF] |
||||
![]() |
D. R. Stewart, B. A. Dombroski, M. Urbanek, W. Ankener, K. G. Ewens, J. R. Wood, R. S. Legro, J. F. Strauss III, A. Dunaif, and R. S. Spielman Fine Mapping of Genetic Susceptibility to Polycystic Ovary Syndrome on Chromosome 19p13.2 and Tests for Regulatory Activity J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4112 - 4117. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.F. Escobar-Morreale, G. Villuendas, J.I. Botella-Carretero, F. Alvarez-Blasco, R. Sanchon, M. Luque-Ramirez, and J.L. San Millan Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study Hum. Reprod., September 1, 2006; 21(9): 2257 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H M Lima, L. C Souza, L. C Caperuto, E. Bevilacqua, A. L Gasparetti, R. Zanuto, M. J A Saad, and C. R O Carvalho Up-regulation of the phosphatidylinositol 3-kinase/protein kinase B pathway in the ovary of rats by chronic treatment with hCG and insulin. J. Endocrinol., August 1, 2006; 190(2): 451 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Lo, S. L. Feigenbaum, G. J. Escobar, J. Yang, Y. M. Crites, and A. Ferrara Increased Prevalence of Gestational Diabetes Mellitus Among Women With Diagnosed Polycystic Ovary Syndrome: A population-based study Diabetes Care, August 1, 2006; 29(8): 1915 - 1917. [Full Text] [PDF] |
||||
![]() |
M. Mohlig, A. Jurgens, J. Spranger, K. Hoffmann, M. O Weickert, H. W Schlosser, T. Schill, G. Brabant, A. Schuring, A. F H Pfeiffer, et al. The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome. Eur. J. Endocrinol., July 1, 2006; 155(1): 127 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.K. Blank, C.R. McCartney, and J.C. Marshall The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome Hum. Reprod. Update, July 1, 2006; 12(4): 351 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Moll, P. M M Bossuyt, J. C Korevaar, C. B Lambalk, and F. van der Veen Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial BMJ, June 24, 2006; 332(7556): 1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pasquali and A. Gambineri Insulin-sensitizing agents in polycystic ovary syndrome. Eur. J. Endocrinol., June 1, 2006; 154(6): 763 - 775. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |